SCHEMBL5474113

SCHEMBL5474113

O=C(Nc1ccc(Br)cc1-c1nnn[nH]1)Nc1cccc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.45
MAPT P10636 4/20 0.45
TRPV1 Q8NER1 2/20 0.45
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 2/20 0.43
ALOX12 P18054 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HPGD P15428 2/20 0.41
GRIK1 P39086 1/20 0.41
GSK3B P49841 1/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1463379 0.86 CXCR1 (0.49) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL1464054 0.84 KMT2A (0.51) KDM4EMAPTTRPV1KMT2AMEN1
SCHEMBL1462965 0.84 DDX3X (0.44) MAPTKMT2AMEN1ALDH1A1GAA
SCHEMBL1462410 0.84 RAB9A (0.51) KDM4EMAPTKMT2AMEN1ALDH1A1
SCHEMBL5468334 0.84 MAPT (0.46) KDM4EMAPTTRPV1KMT2AMEN1
SCHEMBL1463540 0.83 GRIK1 (0.50) KDM4EMAPTTRPV1KMT2AMEN1
SCHEMBL1462381 0.83 MAPT (0.46) MAPTKMT2AMEN1GAAPOLB
SCHEMBL1462366 0.82 ALDH1A1 (0.46) KDM4ETRPV1KMT2AMEN1ALDH1A1
SCHEMBL1463507 0.82 KMT2A (0.45) KDM4EMAPTKMT2AMEN1ALDH1A1
SCHEMBL1464219 0.81 NPC1 (0.46) MAPTKMT2AMEN1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US claimed
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators NEUROSEARCH A/S (DK) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293553-A1 Diphenylurea Derivatives Useful As Potassium Channel Activators KCNJ2, KCNH2, KCNH3 KDM4E 604/4885MAPT 109/4885TRPV1 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.